Industry reports
Editor highlights

Search inside this page

Publishers

All regions

Free Market Research Guides to Download

Pathology Analysis & Statistics, May 2013 (p50)

You might be interested in: cancer, breast cancer, prostate cancer, more »

» Purchase Premium Reports

1471-1520 of about 5 600 reports
Global Intravenous Solutions (Parenteral Nutrition) Industry

Global Intravenous Solutions (Parenteral Nutrition) Industry

  • $ 4 950
  • Industry report
  • July 2013
  • by Global Industry Analysts

This report analyzes the worldwide markets for Intravenous Solutions (Parenteral Nutrition) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, ...

  • Industries : Pathology
  • Countries : World
Global Neurovascular Market: Trends & Opportunities (2013-2018)

Global Neurovascular Market: Trends & Opportunities (2013-2018)

  • $ 750
  • Industry report
  • July 2013
  • by Daedal Research

The term neurovascular implies the assessment of blood flow and sensation to various parts of the body, including brain, spinal cord and blood vessels. Of the various disorders and conditions associated ...

  • Industries : Pathology
  • Countries : World
Global Hearing Aids Market 2012-2016

Global Hearing Aids Market 2012-2016

  • $ 2 500
  • Industry report
  • July 2013
  • by Infiniti Research Limited

TechNavio's analysts forecast the Global Hearing Aids market to grow at a CAGR of 7.17 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing sale ...

  • Industries : Pathology
  • Countries : World
Physician Views: Post ADA view on key diabetes market developments

Physician Views: Post ADA view on key diabetes market developments

  • $ 645
  • Industry report
  • July 2013
  • by Firstword Pharma

Last week's American Diabetes Association (ADA) meeting provided further evidence that the diabetes market is likely to be the pharmaceutical industry's most competitive disease area over the next decade. ...

  • Industries : Pathology
  • Countries : United States
Physician Views: Key developments in the European diabetes market - will endocrinologists embrace Tresiba and Forxiga? - both rejected by the FDA

Physician Views: Key developments in the European diabetes market - will endocrinologists embrace Tresiba and Forxiga? - both rejected by the FDA

  • $ 645
  • Industry report
  • July 2013
  • by Firstword Pharma

Scope of the Report European-based endocrinologists are currently getting to grips with two new products that have been rejected for approval in the US market. Novo Nordisk's long-acting basal insulin ...

  • Industries : Pathology
  • Countries : Europe, United States, World
Hepatitis D - Pipeline Review, H1 2013

Hepatitis D - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • June 2013
  • by Global Markets Direct

Hepatitis D - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Hepatitis D - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information ...

  • Industries : Pathology
  • Countries : World, United States, Japan
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2013

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • June 2013
  • by Global Markets Direct

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 ...

  • Industries : Pathology
  • Countries : World
Pompe Disease - Pipeline Review, H1 2013

Pompe Disease - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • June 2013
  • by Global Markets Direct

Pompe Disease - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Pompe Disease - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Pathology
  • Countries : World
Hemorrhagic Fever - Pipeline Review, H1 2013

Hemorrhagic Fever - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • June 2013
  • by Global Markets Direct

Hemorrhagic Fever - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Hemorrhagic Fever - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report ...

  • Industries : Pathology
  • Countries : World
Rhinovirus Infection - Pipeline Review, H1 2013

Rhinovirus Infection - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • June 2013
  • by Global Markets Direct

Rhinovirus Infection - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Rhinovirus Infection - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This ...

  • Industries : Pathology
  • Countries : World
Retinopathy - Pipeline Review, H1 2013

Retinopathy - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • June 2013
  • by Global Markets Direct

Retinopathy - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Retinopathy - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information ...

  • Industries : Pathology
  • Countries : World
Myeloproliferative Disorders - Pipeline Review, H1 2013

Myeloproliferative Disorders - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • June 2013
  • by Global Markets Direct

Myeloproliferative Disorders - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Myeloproliferative Disorders - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic ...

  • Industries : Pathology
  • Countries : World
Rhabdomyosarcoma - Pipeline Review, H1 2013

Rhabdomyosarcoma - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • June 2013
  • by Global Markets Direct

Rhabdomyosarcoma - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Rhabdomyosarcoma - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Pathology
  • Countries : World
Bullous Pemphigoid - Pipeline Review, H1 2013

Bullous Pemphigoid - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • June 2013
  • by Global Markets Direct

Bullous Pemphigoid - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Bullous Pemphigoid - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report ...

  • Industries : Pathology
  • Countries : World
General Anxiety Disorder - Pipeline Review, H1 2013

General Anxiety Disorder - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • June 2013
  • by Global Markets Direct

General Anxiety Disorder - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'General Anxiety Disorder - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. ...

  • Industries : Pathology
  • Countries : World
Pancreatic Ductal Adenocarcinoma - Pipeline Review, H1 2013

Pancreatic Ductal Adenocarcinoma - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • June 2013
  • by Global Markets Direct

Pancreatic Ductal Adenocarcinoma - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Pancreatic Ductal Adenocarcinoma - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic ...

  • Industries : Pathology
  • Countries : World, United States
Aplastic Anemia - Pipeline Review, H1 2013

Aplastic Anemia - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • June 2013
  • by Global Markets Direct

Aplastic Anemia - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Aplastic Anemia - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Pathology
  • Countries : World
Plague - Pipeline Review, H1 2013

Plague - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • June 2013
  • by Global Markets Direct

Plague - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Plague - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information ...

  • Industries : Pathology
  • Countries : World
Bacterial Vaginosis - Pipeline Review, H1 2013

Bacterial Vaginosis - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • June 2013
  • by Global Markets Direct

Bacterial Vaginosis - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Bacterial Vaginosis - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report ...

  • Industries : Pathology
  • Countries : World
Dilated Cardiomyopathy - Pipeline Review, H1 2013

Dilated Cardiomyopathy - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • June 2013
  • by Global Markets Direct

Dilated Cardiomyopathy - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Dilated Cardiomyopathy - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This ...

  • Industries : Pathology
  • Countries : World
Gastric Ulcers - Pipeline Review, H1 2013

Gastric Ulcers - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • June 2013
  • by Global Markets Direct

Gastric Ulcers - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Gastric Ulcers - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Pathology
  • Countries : United States, World
Blood Cancer - Pipeline Review, H1 2013

Blood Cancer - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • June 2013
  • by Global Markets Direct

Blood Cancer - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Blood Cancer - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Pathology
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline Review, H1 2013

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • June 2013
  • by Global Markets Direct

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline Review, H1 ...

  • Industries : Pathology
  • Countries : World, Canada
Progressive Supranuclear Palsy - Pipeline Review, H1 2013

Progressive Supranuclear Palsy - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • June 2013
  • by Global Markets Direct

Progressive Supranuclear Palsy - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Progressive Supranuclear Palsy- Pipeline Review, H1 2013', provides an overview of the indication's therapeutic ...

  • Industries : Pathology
  • Countries : World
Panic Disorders - Pipeline Review, H1 2013

Panic Disorders - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • June 2013
  • by Global Markets Direct

Panic Disorders - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Panic Disorders - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Pathology
  • Countries : World
Periodontitis - Pipeline Review, H1 2013

Periodontitis - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • June 2013
  • by Global Markets Direct

Periodontitis - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Periodontitis - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Pathology
  • Countries : World
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) - Pipeline Review, H1 2013

Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • June 2013
  • by Global Markets Direct

Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus ...

  • Industries : Pathology
  • Countries : World
Acute Promyelocytic Leukemia - Pipeline Review, H1 2013

Acute Promyelocytic Leukemia - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • June 2013
  • by Global Markets Direct

Acute Promyelocytic Leukemia - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Acute Promyelocytic Leukemia - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic ...

  • Industries : Pathology
  • Countries : World, United States
Ischemic Cerebral Stroke - Pipeline Review, H1 2013

Ischemic Cerebral Stroke - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • June 2013
  • by Global Markets Direct

Ischemic Cerebral Stroke - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Ischemic Cerebral Stroke - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. ...

  • Industries : Pathology
  • Countries : World
World Pathology: Nasopharyngitis (Common Cold) ? Pipeline Review, H1 2012

World Pathology: Nasopharyngitis (Common Cold) ? Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • June 2013
  • by Global Markets Direct

This report provides information on the therapeutic development for Nasopharyngitis (Common Cold), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...

  • Industries : Pathology
  • Countries : World

» View Public Reports

About 12 000 reports

The Australian Pharmaceutical Business Brief

  • Industry report
  • April 2014
  • 8 pages
  • by Corporation

... To compare the expenditure of other chronic diseases, particularly chronic diseases that share many of the same risk factors such as ckd [14]. As a result, this investigation will determine and compare ...

U.s. Diabete Sector

April 2014

» Read our Company Profiles

About 200 Companies

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

Pfizer Inc.

United States

GlaxoSmithKline PLC

United Kingdom

Johnson and Johnson

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.